Breaking News Instant updates and real-time market news.

2020-11-27 10:41:29 MRNA Moderna $124.79 / +15.61 (+14.30%) , NVAX Novavax $118.65 / +16.13 (+15.73%) … 10:41 11/27/20 11/27 10:41 11/27/20 10:41	Moderna, Novavax advance as questions on AstraZeneca COVID vaccine arise Shares of smaller companies in the COVID-19 vaccine race, including Moderna (MRNA) and Novavax (NVAX), are rising in Friday trading as questions have come to the forefront regarding the COVID-19 vaccine candidate being developed by AstraZeneca (AZN) in partnership with the University of Oxford. Argus analyst David Toung has noted that the results generated some "controversy" given how some of the trial participants accidentally received a halved first dose of the vaccine. In an interview with Bloomberg, AstraZeneca CEO Pascal Soriot said the company wants an additional global trial to confirm the 90% efficacy rate that the shot showed in a portion of the existing Phase 3 trial, although he didn't expect the additional trial to hold up regulatory approvals in the U.K. and European Union. In morning trading, Novavax shares have gained $19.13, or 19%, to $121.73, while Moderna shares have advanced $18.81, or 17%, to $127.99. MRNA Moderna $124.79 / +15.61 (+14.30%) NVAX Novavax $118.65 / +16.13 (+15.73%) AZN AstraZeneca $52.14 / -0.46 (-0.87%)	05 Dec 08 Dec 12 Feb 19 May
MRNA NVAX AZN MRNA Moderna $124.79 / +15.61 (+14.30%) 11/27/20 Argus AstraZeneca's COVID vaccine faces high bar for FDA authorization, says Argus 11/25/20 Goldman Sachs Moderna price target raised to $139 from $107 at Goldman Sachs 11/23/20 Fly Intel: Top five analyst initiations 11/23/20 Wells Fargo Moderna initiated with an Equal Weight at Wells Fargo NVAX Novavax $118.65 / +16.13 (+15.73%) 11/17/20 H.C. Wainwright Novavax price target lowered to $207 from $290 at H.C. Wainwright 10/30/20 Cantor Fitzgerald Cantor says Novavax vaccine could be 'best-in-class,' but not 'first-in-class' 10/22/20 B. Riley Securities Novavax price target lowered to $223 from $257 at B. Riley Securities 10/06/20 Raymond James Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov. AZN AstraZeneca $52.14 / -0.46 (-0.87%) 11/27/20 Citi Citi opens 'positive catalyst watch' on AstraZeneca after vaccine selloff 11/24/20 Piper Sandler Astra vaccine results 'de-risking' for Altimmune, says Piper Sandler 11/23/20 Morgan Stanley AstraZeneca price target raised to 9,400 GBp from 9,000 GBp at Morgan Stanley

2020-11-27 10:41:29

MRNA

Moderna

$124.79 / +15.61 (+14.30%)

, NVAX

Novavax

$118.65 / +16.13 (+15.73%)

… 10:41

11/27/20

11/27

10:41

11/27/20

10:41

Moderna, Novavax advance as questions on AstraZeneca COVID vaccine arise

Shares of smaller companies in the COVID-19 vaccine race, including Moderna (MRNA) and Novavax (NVAX), are rising in Friday trading as questions have come to the forefront regarding the COVID-19 vaccine candidate being developed by AstraZeneca (AZN) in partnership with the University of Oxford. Argus analyst David Toung has noted that the results generated some "controversy" given how some of the trial participants accidentally received a halved first dose of the vaccine. In an interview with Bloomberg, AstraZeneca CEO Pascal Soriot said the company wants an additional global trial to confirm the 90% efficacy rate that the shot showed in a portion of the existing Phase 3 trial, although he didn't expect the additional trial to hold up regulatory approvals in the U.K. and European Union. In morning trading, Novavax shares have gained $19.13, or 19%, to $121.73, while Moderna shares have advanced $18.81, or 17%, to $127.99.

MRNA

Moderna

$124.79 / +15.61 (+14.30%)

NVAX

Novavax

$118.65 / +16.13 (+15.73%)

AZN

AstraZeneca

$52.14 / -0.46 (-0.87%)

05
Dec
08
Dec

12
Feb
19
May

MRNA
NVAX
AZN

MRNA Moderna

$124.79 / +15.61 (+14.30%)

11/27/20 Argus: AstraZeneca's COVID vaccine faces high bar for FDA authorization, says Argus

11/25/20 Goldman Sachs: Moderna price target raised to $139 from $107 at Goldman Sachs

11/23/20: Fly Intel: Top five analyst initiations

11/23/20 Wells Fargo: Moderna initiated with an Equal Weight at Wells Fargo

NVAX Novavax

$118.65 / +16.13 (+15.73%)

11/17/20 H.C. Wainwright: Novavax price target lowered to $207 from $290 at H.C. Wainwright

10/30/20 Cantor Fitzgerald: Cantor says Novavax vaccine could be 'best-in-class,' but not 'first-in-class'

10/22/20 B. Riley Securities: Novavax price target lowered to $223 from $257 at B. Riley Securities

10/06/20 Raymond James: Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.

AZN AstraZeneca

$52.14 / -0.46 (-0.87%)

11/27/20 Citi: Citi opens 'positive catalyst watch' on AstraZeneca after vaccine selloff

11/24/20 Piper Sandler: Astra vaccine results 'de-risking' for Altimmune, says Piper Sandler

11/23/20 Morgan Stanley: AstraZeneca price target raised to 9,400 GBp from 9,000 GBp at Morgan Stanley

TODAY'S FREE FLY STORIES

Options	Nordstrom options imply 13.1% move in share price post-earnings » 15:04 03/02/21 03/02 15:04 03/02/21 15:04 JWN Nordstrom $37.60 / -0.35 (-0.92%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options JWN Nordstrom $37.60 / -0.35 (-0.92%) 03/01/21 Nordstrom, Tonal form partnership 02/04/21 Nordstrom turns negative, down 2% after issuing guidance 02/04/21 Nordstrom trading resumes 02/04/21 Nordstrom says 'focused on accelerating revenue growth, expanding profit margin' JWN Nordstrom $37.60 / -0.35 (-0.92%) 02/16/21 JPMorgan Nordstrom price target raised to $40 from $34 at JPMorgan 02/10/21 Gordon Haskett Nordstrom upgraded to Buy from Hold at Gordon Haskett 01/21/21 Deutsche Bank Nordstrom price target raised to $43 from $24 at Deutsche Bank 01/14/21 Credit Suisse Nordstrom price target raised to $39 from $26 at Credit Suisse JWN Nordstrom $37.60 / -0.35 (-0.92%) 02/04/21 Nordstrom gives long-term outlook, sees sales growing low single-digits annually 02/04/21 Nordstrom sees 2021 revenue up more than 25%, EBIT positive 02/04/21 Nordstrom reiterates Q4 outlook, sees sales down low 20 percent range 11/24/20 Nordstrom sees Q4 sales down in the low 20% range, consensus $4.01B JWN Nordstrom $37.60 / -0.35 (-0.92%) 01/02/21 Nordstrom looks like a department store survivor, Barron's says JWN Nordstrom $37.60 / -0.35 (-0.92%) 01/14/21 Fly Intel: Pre-market Movers 01/13/21 Fly Intel: After-Hours Movers 12/31/20 Alphabet, Nordstrom target changes among today's top calls on Wall Street 11/24/20 Fly Intel: After-Hours Movers 16:45 Today Nordstrom - JWN JWN Nordstrom $37.60 / -0.35 (-0.92%) 01/29/21 Nordstrom put buyer realizes 156% same-day gains 01/25/21 Early notable gainers among liquid option names on January 25th 12/31/20 Early notable gainers among liquid option names on December 31st 12/30/20 Early notable gainers among liquid option names on December 30th
Recommendations	ASM International price target raised to EUR 250 from EUR 210 at Deutsche Bank » 15:03 03/02/21 03/02 15:03 03/02/21 15:03 ASMIY ASM International $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ASMIY ASM International $0.00 / + (+0.00%) 03/01/21 Barclays ASM International price target raised to EUR 250 from EUR 210 at Barclays 03/01/21 Credit Suisse ASM International price target raised to EUR 265 from EUR 250 at Credit Suisse 01/25/21 Credit Suisse ASM International price target raised to EUR 250 from EUR 204 at Credit Suisse 01/14/21 Barclays ASM International price target raised to EUR 210 from EUR 180 at Barclays
Recommendations	Vestas price target raised to DKK 1,350 from DKK 1,300 at Berenberg » 15:03 03/02/21 03/02 15:03 03/02/21 15:03 VWDRY Vestas $0.00 / + (+0.00%) Berenberg analyst Henry… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research VWDRY Vestas $0.00 / + (+0.00%) 02/26/21 BofA Vestas removed from Europe 1 list at BofA 02/25/21 UBS Vestas upgraded to Buy from Neutral at UBS 02/11/21 Deutsche Bank Vestas price target lowered to DKK 1,460 from DKK 1,500 at Deutsche Bank 02/08/21 Deutsche Bank Vestas price target lowered to DKK 1,500 from DKK 1,630 at Deutsche Bank
Recommendations	Rightmove price target raised to 455 GBp from 440 GBp at Berenberg » 15:02 03/02/21 03/02 15:02 03/02/21 15:02 RTMVY Rightmove $0.00 / + (+0.00%) Berenberg analyst Robert… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research RTMVY Rightmove $0.00 / + (+0.00%) 02/24/21 Deutsche Bank Rightmove price target raised to 600 GBp from 540 GBp at Deutsche Bank 02/04/21 UBS Rightmove price target raised to 630 GBp from 620 GBp at UBS 01/29/21 Barclays Rightmove price target lowered to 550 GBp from 575 GBp at Barclays 01/20/21 BofA Rightmove downgraded to Underperform from Neutral at BofA
Recommendations	Rational price target raised to EUR 625 from EUR 620 at Berenberg » 15:01 03/02/21 03/02 15:01 03/02/21 15:01 RTLLF Rational $0.00 / + (+0.00%) Berenberg analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research RTLLF Rational $0.00 / + (+0.00%) 01/29/21 Deutsche Bank Rational downgraded to Sell from Hold at Deutsche Bank 01/19/21 Berenberg Rational price target raised to EUR 620 from EUR 610 at Berenberg 10/29/20 HSBC Rational downgraded to Reduce from Hold at HSBC 09/15/20 Berenberg Rational downgraded to Hold from Buy at Berenberg

Recommendations	Klepierre price target raised to EUR 23 from EUR 18.50 at Berenberg » 15:01 03/02/21 03/02 15:01 03/02/21 15:01 KLPEF Klepierre $0.00 / + (+0.00%) Berenberg analyst Kai… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research KLPEF Klepierre $0.00 / + (+0.00%) 02/18/21 Deutsche Bank Klepierre price target lowered to EUR 20 from EUR 21.50 at Deutsche Bank 01/22/21 Deutsche Bank Klepierre price target lowered to EUR 21.50 from EUR 23 at Deutsche Bank 01/18/21 BofA Klepierre downgraded to Underperform from Neutral at BofA 01/15/21 JPMorgan Klepierre price target lowered to EUR 20 from EUR 22 at JPMorgan
Recommendations	IAG price target raised to 230 GBp from 190 GBp at Berenberg » 15:01 03/02/21 03/02 15:01 03/02/21 15:01 ICAGY IAG $0.00 / + (+0.00%) Berenberg analyst Adrian… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Periodicals ICAGY IAG $0.00 / + (+0.00%) 03/01/21 Peel Hunt IAG upgraded to Buy from Hold at Peel Hunt 02/23/21 BofA BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list 01/27/21 Berenberg IAG price target raised to 190 GBp from 180 GBp at Berenberg 01/22/21 Kepler Cheuvreux IAG downgraded to Reduce from Hold at Kepler Cheuvreux ICAGY IAG $0.00 / + (+0.00%) 12/07/20 IAG dismisses Ryanair comments on British Airways holding, Reuters says 11/05/20 British Airways to reduce flight schedule in November, Reuters reports
Recommendations	Fresenius Medical price target lowered to EUR 79.50 from EUR 80.40 at Berenberg » 15:00 03/02/21 03/02 15:00 03/02/21 15:00 FMS Fresenius Medical $35.31 / +0.26 (+0.74%) Berenberg analyst Tom… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals Events FMS Fresenius Medical $35.31 / +0.26 (+0.74%) 02/10/21 Model N discloses J&J agreed to transition to its Revenue Cloud for Life Science 01/19/21 CytoSorb approved in Korea for all EU approved indications FMS Fresenius Medical $35.31 / +0.26 (+0.74%) 02/26/21 JPMorgan Fresenius Medical price target raised to EUR 52.40 from EUR 51.10 at JPMorgan 02/24/21 Truist Fresenius Medical cut to Hold at Truist on more difficult operating backdrop 02/24/21 Truist Fresenius Medical downgraded to Hold from Buy at Truist 02/17/21 UBS Fresenius Medical price target lowered to EUR 72 from EUR 94 at UBS FMS Fresenius Medical $35.31 / +0.26 (+0.74%) 12/30/20 Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says 00:00 Today 2021 London Global Healthcare Virtual Conference
Options	Callapalozza in Rocket Mortage echoes Gamestop squeeze » 15:00 03/02/21 03/02 15:00 03/02/21 15:00 RKT Rocket Companies $37.99 / +13.69 (+56.34%) Callapalozza in Rocket… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options RKT Rocket Companies $37.99 / +13.69 (+56.34%) 14:32 Today Rocket Companies soars as short interest gets highlighted 14:16 Today Rocket resumes trading after volatility halt, shares up 57% to $38.07 14:15 Today Rocket Companies trading resumes 14:10 Today Rocket Companies trading halted, volatility trading pause RKT Rocket Companies $37.99 / +13.69 (+56.34%) 01/19/21 JPMorgan JPMorgan double downgrades Rocket on more cautious mortgage stance 01/19/21 JPMorgan Rocket Companies downgraded to Underweight from Overweight at JPMorgan 12/17/20 Keefe Bruyette Rocket Companies downgraded to Underperform at Keefe Bruyette 12/14/20 Fly Intel: Top five analyst initiations RKT Rocket Companies $37.99 / +13.69 (+56.34%) 02/25/21 Rocket Companies reports Q4 adjusted EPS $1.14, consensus 87c 02/25/21 Notable companies reporting after market close 11/10/20 Rocket Companies sees Q4 closed loan volume $88B-93B 11/10/20 Rocket Companies reports Q3 EPS 54c, consensus $1.09 06 Aug RKT Rocket Companies $37.99 / +13.69 (+56.34%) 10/01/20 Realtor.com announces new partnership with Rocket Mortgage, Inman reports RKT Rocket Companies $37.99 / +13.69 (+56.34%) 02/25/21 Fly Intel: After-Hours Movers 11/10/20 Fly Intel: After-Hours Movers 09/02/20 Fly Intel: After-Hours Movers RKT Rocket Companies $37.99 / +13.69 (+56.34%) 09:40 Today Unusually active option classes on open March 2nd 03/01/21 Rocket Companies call volume above normal and directionally bullish 03/01/21 Unusually active option classes on open March 1st 02/25/21 Rocket Companies options imply 18.1% move in share price post-earnings
Recommendations	BAE Systems price target raised to 600 GBp from 590 GBp at Berenberg » 14:59 03/02/21 03/02 14:59 03/02/21 14:59 BAESY BAE Systems $0.00 / + (+0.00%) Berenberg analyst Andrew… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly BAESY BAE Systems $0.00 / + (+0.00%) 09:15 Today BAE Systems gets $58M Boeing contract for LRIP of the EPAWSS by USAF 02/18/21 BAE Systems gets order from the Norwegian army for more CV90s 02/17/21 BAE Systems gets contract to develop advanced military GPS receivers and chips 02/10/21 BAE Systems awarded $183.84M Navy contract modification BAESY BAE Systems $0.00 / + (+0.00%) 02/11/21 Deutsche Bank BAE Systems price target lowered to 660 GBp from 685 GBp at Deutsche Bank 02/11/21 Morgan Stanley BAE Systems price target raised to 647 GBp from 630 GBp at Morgan Stanley 02/10/21 Deutsche Bank BAE Systems price target lowered to 660 GBp from 685 GBp at Deutsche Bank 01/19/21 Credit Suisse BAE Systems price target lowered to 615 GBp from 645 GBp at Credit Suisse BAESY BAE Systems $0.00 / + (+0.00%) 01/02/21 Congress overturns Trump veto on Defense bill, NPR reports BAESY BAE Systems $0.00 / + (+0.00%) 01/02/21 Week in review: How Trump's policies moved stocks 12/26/20 Week in review: How Trump's policies moved stocks 12/19/20 Week in review: How Trump's policies moved stocks

Recommendations	Grifols price target lowered to EUR 23 from EUR 26.50 at JPMorgan » 14:55 03/02/21 03/02 14:55 03/02/21 14:55 GRFS Grifols $16.26 / -0.21 (-1.28%) JPMorgan analyst James… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research GRFS Grifols $16.26 / -0.21 (-1.28%) 01/28/21 Grifols announces publication of article on Phase 2 clinical trial of GRF6019 01/18/21 Grifols to begin clinical trial in Spain for new COVID-19 drug 11/13/20 Soros takes stake in Palantir, exits TransDigm position 11/09/20 Grifols acquires remaining 49% of Goetech for $60.2M GRFS Grifols $16.26 / -0.21 (-1.28%) 02/12/21 Berenberg Grifols price target lowered to EUR 23 from EUR 24.50 at Berenberg 01/22/21 Barclays Grifols price target lowered to EUR 31 from EUR 32 at Barclays 01/20/21 Credit Suisse Grifols price target lowered to EUR 26 from EUR 27 at Credit Suisse 01/13/21 Morgan Stanley Grifols price target lowered to EUR 31 from EUR 32 at Morgan Stanley
Recommendations	Hellenic Telecom price target raised to EUR 15.60 from EUR 15.40 at JPMorgan » 14:53 03/02/21 03/02 14:53 03/02/21 14:53 HLTOY Hellenic Telecom $0.00 / + (+0.00%) JPMorgan analyst Roman… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research HLTOY Hellenic Telecom $0.00 / + (+0.00%) 02/09/21 JPMorgan Hellenic Telecom price target lowered to EUR 15.40 from EUR 15.90 at JPMorgan 11/13/20 JPMorgan Hellenic Telecom price target raised to EUR 15.90 from EUR 15.70 at JPMorgan 10/23/20 Barclays Hellenic Telecom downgraded to Underweight from Overweight at Barclays 08/07/20 JPMorgan Hellenic Telecom price target raised to EUR 15.70 from EUR 15 at JPMorgan
Options	AMC Entertainment options imply 18.3% move in share price post-earnings » 14:49 03/02/21 03/02 14:49 03/02/21 14:49 AMC AMC Entertainment $8.86 / -0.345 (-3.75%) Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AMC AMC Entertainment $8.86 / -0.345 (-3.75%) 02/25/21 AMC Entertainment rises 16.6% 02/24/21 EPR Properties recognizing revenue from AMC, Regal on cash basis 02/24/21 AMC jumps, GameStop shares more than double in late day spike 02/23/21 AMC Entertainment rises 10.7% AMC AMC Entertainment $8.86 / -0.345 (-3.75%) 02/04/21 Citi Citi sees 'dramatically reduced' bankruptcy risk for AMC Entertainment 02/01/21 MKM Partners AMC Entertainment downgraded to Sell from Neutral at MKM Partners 02/01/21 MKM Partners AMC Entertainment downgraded to Sell from Neutral at MKM Partners 01/26/21 Loop Capital AMC Entertainment's capital raise results in massive dilution, says Loop Capital AMC AMC Entertainment $8.86 / -0.345 (-3.75%) 11/02/20 AMC Entertainment reports Q3 adjusted EPS ($5.70), consensus ($4.95) 11/02/20 Notable companies reporting after market close 10/20/20 AMC Entertainment sees Q3 revenue roughly $119.5M, consensus $155.31M AMC AMC Entertainment $8.86 / -0.345 (-3.75%) 02/22/21 Movie theaters might get OK to reopen in New York City, Deadline says 02/18/21 AMC rumored to have had conversations with Amazon, Forbes reports 02/11/21 DOJ, other regulators probing frenzy that drove up GameStop, WSJ says 02/05/21 Robinhood removes trading restrictions on GameStop, others, Reuters reports AMC AMC Entertainment $8.86 / -0.345 (-3.75%) 02/23/21 Fly Intel: Wall Street's top stories for Tuesday 02/23/21 Fly Intel: Wall Street's top stories at midday 02/23/21 Fly Intel: Pre-market Movers 02/08/21 Fly Intel: Wall Street's top stories for Monday 03/10/21 AMC Entertainment - AMC AMC AMC Entertainment $8.86 / -0.345 (-3.75%) 08:55 Today Notable open interest changes for March 2nd 02/26/21 Notable open interest changes for February 26th 02/25/21 Unusually active option classes on open February 25th 02/25/21 Notable open interest changes for February 25th
Recommendations	Eaton price target raised to $140 from $120 at Baird » 14:46 03/02/21 03/02 14:46 03/02/21 14:46 ETN Eaton $134.04 / -0.17 (-0.13%) Baird analyst Mircea… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals ETN Eaton $134.04 / -0.17 (-0.13%) 02/24/21 Eaton raises quarterly dividend 4% to 76c per share 02/01/21 Eaton to acquire Cobham Mission Systems for $2.83B 01/29/21 Eaton to acquire Tripp Lite for $1.65B 01/04/21 Eaton appoints Katrina Redmond as SVP, CIO ETN Eaton $134.04 / -0.17 (-0.13%) 06:50 Today Oppenheimer Eaton price target raised to $145 from $133 at Oppenheimer 02/16/21 Eaton participates in a conference call with Wolfe Research 02/16/21 Fly Intel: Top five analyst upgrades 02/16/21 HSBC Eaton upgraded to Buy from Hold at HSBC ETN Eaton $134.04 / -0.17 (-0.13%) 02/02/21 Eaton sees Q1 adjusted EPS $1.17-$1.27, consensus $1.05 02/02/21 Eaton sees FY21 adjusted EPS $5.40-$5.80, consensus $4.83 02/02/21 Eaton reports Q4 adjusted EPS $1.28, consensus $1.20 11/03/20 Eaton sees FY20 operating cash flow $2.8B-$3.0B ETN Eaton $134.04 / -0.17 (-0.13%) 12/19/20 Alphabet, Apple among Barron's 10 Top stocks for 2021, Barron's says
Hot Stocks	Facebook dips as TMT conference presentation continues » 14:41 03/02/21 03/02 14:41 03/02/21 14:41 FB Facebook $263.65 / -0.73 (-0.28%) Shares of Facebook (FB)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FB Facebook $263.65 / -0.73 (-0.28%) 03/01/21 Instagram launches Live Rooms feature for Live with up to three people 03/01/21 AudioEye announces Zach Okun as chief product officer 03/01/21 Instagram head Adam Mosseri teases feature announcement for 11am ET 02/23/21 Facebook to restore news access on its platform in Australia FB Facebook $263.65 / -0.73 (-0.28%) 02/26/21 Jefferies Twitter price target raised to $79 from $64 at Jefferies 02/16/21 Loop Capital Facebook price target raised to $370 from $330 at Loop Capital 02/10/21 Tigress Financial Facebook has 'significant upside' at current levels, says Tigress 02/01/21 Truist Alphabet price target raised to $2,100 from $2,000 at Truist FB Facebook $263.65 / -0.73 (-0.28%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 01/27/21 Facebook reports Q4 EPS $3.88, consensus $3.22 01/27/21 Notable companies reporting after market close 10/29/20 Facebook sees Q4 ad revenue growth rate higher than Q3 FB Facebook $263.65 / -0.73 (-0.28%) 02/28/21 Reliance partners with Google, Facebook for payment network bid, Reuters says 02/24/21 Facebook exploring potential media licensing agreements in Canada, Reuters says 02/21/21 White House working with Facebook, Twitter to tackle anti-vaxxers, Reuters says 02/21/21 Gates says social media bans not answer to divisiveness, Bloomberg reports FB Facebook $263.65 / -0.73 (-0.28%) 02/28/21 Opening Day: Coinbase files to go public 02/24/21 #SocialStocks: Snap shares advance following first investor day 02/23/21 Fly Intel: Wall Street's top stories at midday 02/22/21 Before the Move: Watch Snap ahead of first investor day meeting 03/17/21 Technology 00:00 Today Technology, Media & Telecom Virtual Conference FB Facebook $263.65 / -0.73 (-0.28%) 02/16/21 Facebook call volume above normal and directionally bullish 01/27/21 Facebook options imply 11.6% move in share price post-earnings 01/15/21 Facebook call volume above normal and directionally bullish 12/21/20 Facebook call buyer realizes 33% same-day gains

Hot Stocks	DuPont names Christopher Raia as Chief Human Resources Officer » 14:39 03/02/21 03/02 14:39 03/02/21 14:39 DD DuPont $73.54 / + (+0.00%) DuPont announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options DD DuPont $73.54 / + (+0.00%) 02/11/21 DuPont acquires Tex Tech's Core Matrix Technology 02/01/21 International PE consortium to buy DuPont Clean Technologies for $510M in cash 02/01/21 DuPont to sell clean technologies business to consortium for $510M 02/01/21 DuPont completes IFF and Nutrition & Biosciences merger, receives $7.3B DD DuPont $73.54 / + (+0.00%) 02/11/21 DZ Bank DuPont upgraded to Hold from Sell at DZ Bank 02/03/21 BofA DuPont upgraded to Buy from Neutral at BofA 02/03/21 Wells Fargo DuPont price target lowered to $87 from $95 at Wells Fargo 02/02/21 Deutsche Bank DuPont attractively valued after separation, says Deutsche Bank DD DuPont $73.54 / + (+0.00%) 02/18/21 Eltek sees FY20 revenue approximately $36.7M vs. $34.8M a year ago 02/09/21 DuPont sees FY21 adjusted EPS $3.30-$3.45, consensus $3.07 02/09/21 DuPont sees Q1 adjusted EPS 75c-77c, consensus 64c 02/09/21 DuPont reports Q4 adjusted EPS 95c, consensus 89c DD DuPont $73.54 / + (+0.00%) 02/01/21 Fly Intel: Pre-market Movers DD DuPont $73.54 / + (+0.00%) 01/29/21 Notable open interest changes for January 29th 12/15/20 DuPont de Nemours call volume above normal and directionally bullish 10/28/20 DuPont de Nemours call volume above normal and directionally bullish 09/25/20 DuPont de Nemours call volume above normal and directionally bullish
Hot Stocks	ITC to investigate certain cellular devices made by Samsung, Motorola Mobility » 14:37 03/02/21 03/02 14:37 03/02/21 14:37 SSNLF Samsung $0.00 / + (+0.00%) , LNVGY Lenovo $0.00 / + (+0.00%) The U.S. International… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly SSNLF SSNLF Samsung $0.00 / + (+0.00%) 02/19/21 Solas OLED announces patent dispute settlement with LG Display 01/27/21 Samsung sees Memory business recovering during H1 01/17/21 Fly Intel: Top five weekend stock stories 12/08/20 Genius Brands enters deal with LG Electronics USA for Kartoon Channel! app SSNLF LNVGY SSNLF Samsung $0.00 / + (+0.00%) 02/04/21 Craig-Hallum Qorvo price target raised to $195 from $160 at Craig-Hallum 02/04/21 Craig-Hallum Digital Turbine price target raised to $80 from $60 at Craig-Hallum 01/29/21 Needham Skyworks price target raised to $245 from $200 at Needham 01/26/21 Applied Materials upgraded to Buy at DA Davidson on semicap strength LNVGY Lenovo $0.00 / + (+0.00%) 01/14/21 JPMorgan Lenovo upgraded to Overweight from Neutral at JPMorgan 01/11/21 Credit Suisse Lenovo upgraded to Outperform from Neutral at Credit Suisse 11/03/20 BofA Lenovo upgraded to Buy from Neutral at BofA 05/21/20 JPMorgan Lenovo downgraded to Neutral from Overweight at JPMorgan SSNLF SSNLF Samsung $0.00 / + (+0.00%) 01/27/21 Samsung sees overall profit weakening in Q1 01/27/21 Samsung reports Q4 operating profit KRW9.05T 01/07/21 Samsung sees Q4 operating profit KRW9.00T vs. KRW9.52T consensus 10/28/20 Samsung reports Q3 operating profit KRW12.35T vs KRW7.78T last year SSNLF LNVGY SSNLF Samsung $0.00 / + (+0.00%) 02/17/21 Samsung, NXP, Infineon have power shut off in Austin, AAS reports 02/05/21 Samsung eyes Austin, Texas for new $17B chip plant, Reuters reports 01/27/21 Samsung reports Q4 operating profit 9.05T won, Bloomberg says 01/25/21 Samsung may invest up to $17B in new U.S. chip factory, WSJ reports LNVGY Lenovo $0.00 / + (+0.00%) 12/01/20 Samsung may drop Galaxy Note amid Covid hit on pricey phones, Reuters says SSNLF SSNLF Samsung $0.00 / + (+0.00%) 02/03/21 Fly Intel: What to watch in Qualcomm's earnings report 01/21/21 Fly Intel: What to watch in Intel's earnings report 01/12/21 On, Lumentum seen among top semiconductors takeout candidates for 2021
General news	Treasury Action: trading has been consolidative today » 14:35 03/02/21 03/02 14:35 03/02/21 14:35 Treasury Action: trading… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Rocket Companies soars as short interest gets highlighted » 14:32 03/02/21 03/02 14:32 03/02/21 14:32 RKT Rocket Companies $37.86 / +13.56 (+55.80%) Shares of Rocket… Shares of Rocket Companies are soaring after CNBC mentioned earlier today that the company could be the next target of Reddit target given its high short interest. Rocket's short interest as a percent of the float stands at 46%, according to S3 partners, Bloomberg reports. The stock is up 52%, or $12.60, to $36.90 in afternoon trading. Reference Link ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options RKT Rocket Companies $37.86 / +13.56 (+55.80%) 14:16 Today Rocket resumes trading after volatility halt, shares up 57% to $38.07 14:15 Today Rocket Companies trading resumes 14:10 Today Rocket Companies trading halted, volatility trading pause 12:00 Today Rocket Companies rises 19.2% RKT Rocket Companies $37.86 / +13.56 (+55.80%) 01/19/21 JPMorgan JPMorgan double downgrades Rocket on more cautious mortgage stance 01/19/21 JPMorgan Rocket Companies downgraded to Underweight from Overweight at JPMorgan 12/17/20 Keefe Bruyette Rocket Companies downgraded to Underperform at Keefe Bruyette 12/14/20 Fly Intel: Top five analyst initiations RKT Rocket Companies $37.86 / +13.56 (+55.80%) 02/25/21 Rocket Companies reports Q4 adjusted EPS $1.14, consensus 87c 02/25/21 Notable companies reporting after market close 11/10/20 Rocket Companies sees Q4 closed loan volume $88B-93B 11/10/20 Rocket Companies reports Q3 EPS 54c, consensus $1.09 06 Aug RKT Rocket Companies $37.86 / +13.56 (+55.80%) 10/01/20 Realtor.com announces new partnership with Rocket Mortgage, Inman reports RKT Rocket Companies $37.86 / +13.56 (+55.80%) 02/25/21 Fly Intel: After-Hours Movers 11/10/20 Fly Intel: After-Hours Movers 09/02/20 Fly Intel: After-Hours Movers RKT Rocket Companies $37.86 / +13.56 (+55.80%) 09:40 Today Unusually active option classes on open March 2nd 03/01/21 Rocket Companies call volume above normal and directionally bullish 03/01/21 Unusually active option classes on open March 1st 02/25/21 Rocket Companies options imply 18.1% move in share price post-earnings
Technical Analysis	NASDAQ market internals summary » 14:17 03/02/21 03/02 14:17 03/02/21 14:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 13:17 Today NASDAQ market internals summary 12:17 Today NASDAQ market internals summary 11:17 Today NASDAQ market internals summary 10:17 Today NASDAQ market internals summary

Hot Stocks	Rocket resumes trading after volatility halt, shares up 57% to $38.07 14:16 03/02/21 03/02 14:16 03/02/21 14:16 RKT Rocket Companies $39.21 / +14.91 (+61.36%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options RKT Rocket Companies $39.21 / +14.91 (+61.36%) 14:15 Today Rocket Companies trading resumes 14:10 Today Rocket Companies trading halted, volatility trading pause 12:00 Today Rocket Companies rises 19.2% 10:00 Today Rocket Companies rises 18.7% RKT Rocket Companies $39.21 / +14.91 (+61.36%) 01/19/21 JPMorgan JPMorgan double downgrades Rocket on more cautious mortgage stance 01/19/21 JPMorgan Rocket Companies downgraded to Underweight from Overweight at JPMorgan 12/17/20 Keefe Bruyette Rocket Companies downgraded to Underperform at Keefe Bruyette 12/14/20 Fly Intel: Top five analyst initiations RKT Rocket Companies $39.21 / +14.91 (+61.36%) 02/25/21 Rocket Companies reports Q4 adjusted EPS $1.14, consensus 87c 02/25/21 Notable companies reporting after market close 11/10/20 Rocket Companies sees Q4 closed loan volume $88B-93B 11/10/20 Rocket Companies reports Q3 EPS 54c, consensus $1.09 06 Aug RKT Rocket Companies $39.21 / +14.91 (+61.36%) 10/01/20 Realtor.com announces new partnership with Rocket Mortgage, Inman reports RKT Rocket Companies $39.21 / +14.91 (+61.36%) 02/25/21 Fly Intel: After-Hours Movers 11/10/20 Fly Intel: After-Hours Movers 09/02/20 Fly Intel: After-Hours Movers RKT Rocket Companies $39.21 / +14.91 (+61.36%) 09:40 Today Unusually active option classes on open March 2nd 03/01/21 Rocket Companies call volume above normal and directionally bullish 03/01/21 Unusually active option classes on open March 1st 02/25/21 Rocket Companies options imply 18.1% move in share price post-earnings
Technical Analysis	NYSE market internals summary » 14:16 03/02/21 03/02 14:16 03/02/21 14:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 13:16 Today NYSE market internals summary 12:16 Today NYSE market internals summary 11:16 Today NYSE market internals summary 10:16 Today NYSE market internals summary
Hot Stocks	Rocket Companies trading resumes 14:15 03/02/21 03/02 14:15 03/02/21 14:15 RKT Rocket Companies $39.40 / +15.1 (+62.14%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options RKT Rocket Companies $39.40 / +15.1 (+62.14%) 14:10 Today Rocket Companies trading halted, volatility trading pause 12:00 Today Rocket Companies rises 19.2% 10:00 Today Rocket Companies rises 18.7% 09:47 Today Rocket Companies rises 14.6% RKT Rocket Companies $39.40 / +15.1 (+62.14%) 01/19/21 JPMorgan JPMorgan double downgrades Rocket on more cautious mortgage stance 01/19/21 JPMorgan Rocket Companies downgraded to Underweight from Overweight at JPMorgan 12/17/20 Keefe Bruyette Rocket Companies downgraded to Underperform at Keefe Bruyette 12/14/20 Fly Intel: Top five analyst initiations RKT Rocket Companies $39.40 / +15.1 (+62.14%) 02/25/21 Rocket Companies reports Q4 adjusted EPS $1.14, consensus 87c 02/25/21 Notable companies reporting after market close 11/10/20 Rocket Companies sees Q4 closed loan volume $88B-93B 11/10/20 Rocket Companies reports Q3 EPS 54c, consensus $1.09 06 Aug RKT Rocket Companies $39.40 / +15.1 (+62.14%) 10/01/20 Realtor.com announces new partnership with Rocket Mortgage, Inman reports RKT Rocket Companies $39.40 / +15.1 (+62.14%) 02/25/21 Fly Intel: After-Hours Movers 11/10/20 Fly Intel: After-Hours Movers 09/02/20 Fly Intel: After-Hours Movers RKT Rocket Companies $39.40 / +15.1 (+62.14%) 09:40 Today Unusually active option classes on open March 2nd 03/01/21 Rocket Companies call volume above normal and directionally bullish 03/01/21 Unusually active option classes on open March 1st 02/25/21 Rocket Companies options imply 18.1% move in share price post-earnings
Hot Stocks	Humanigen says COVID trial not suspended, error being corrected by NIH » 14:12 03/02/21 03/02 14:12 03/02/21 14:12 HGEN Humanigen $17.00 / -1.43 (-7.76%) Humanigen tweeted:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options HGEN Humanigen $17.00 / -1.43 (-7.76%) 07:20 Today Humanigen awarded two patents from USPTO 02/03/21 Avid, Humanigen enter into cGMP manufacturing agreement for lenzilumab 02/03/21 Avid Bioservices, Humanigen enter lenzilumab manufacturing services agreement 01/29/21 Humanigen completes enrollment in lenzilumab study for COVID-19 HGEN Humanigen $17.00 / -1.43 (-7.76%) 02/23/21 JPMorgan Humanigen initiated with a Neutral at JPMorgan 01/20/21 Jefferies Jefferies reads Humanigen COVID-19 trial change as 'sign of confidence' 12/23/20 National Securities Humanigen initiated with a Buy at National Securities 12/22/20 Fly Intel: Top five analyst initiations HGEN Humanigen $17.00 / -1.43 (-7.76%) 11/11/20 Humanigen reports Q3 EPS (71c), consensus (49c) 18 Sep HGEN Humanigen $17.00 / -1.43 (-7.76%) 12/17/20 Fly Intel: Wall Street's top stories for Thursday 12/17/20 Fly Intel: Wall Street's top stories at midday 11/06/20 Fly Intel: Wall Street's top stories for Friday 11/06/20 Fly Intel: Wall Street's top stories at midday 03/16/21 31st Annual Healthcare Virtual Conference HGEN Humanigen $17.00 / -1.43 (-7.76%) 09/30/20 Thirteen new option listings and two option delistings on September 30th
Periodicals	Disney CEO says Hollywood's film release model altered from Covid, The Wrap says » 14:11 03/02/21 03/02 14:11 03/02/21 14:11 DIS Disney $194.43 / -0.7 (-0.36%) The Disney CEO Bob Chapek… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options DIS Disney $194.43 / -0.7 (-0.36%) 13:24 Today Epic Games acquires Tonic Games Group, terms not disclosed 13:09 Today Epic Games acquires 'Fall Guys' developer Mediatonic 02/24/21 Disneyland Resort announces Touch of Disney limited-capacity ticketed experience 02/24/21 Disney+ says original series Loki starts streaming on June 11 DIS Disney $194.43 / -0.7 (-0.36%) 02/25/21 Craig-Hallum Magnite price target raised to $72 from $63 at Craig-Hallum 02/25/21 Citi Disney price target raised to $230 from $205 at Citi 02/23/21 Credit Suisse SeaWorld price target raised to $52 from $34 at Credit Suisse 02/17/21 Argus Disney price target raised to $225 from $200 at Argus DIS Disney $194.43 / -0.7 (-0.36%) 02/11/21 Disney reports Q1 EPS ex-items 32c, consensus (41c) 02/11/21 Notable companies reporting after market close 11/12/20 Disney sees FY21 results continuing to be affected by COVID-19 11/12/20 Disney reports Q4 EPS ex-items (20c), consensus (71c) DIS Disney $194.43 / -0.7 (-0.36%) 02/26/21 NFL says 'don't negotiate through media,' SBJ report on Disney deal 'incorrect' 02/26/21 NFL tells Bloomberg that report on rights deal with Disney's ESPN 'incorrect' 02/26/21 Disney reaches agreement with NFL on new rights deal, SBJ reports 02/19/21 Apple demands Steam sales data from Valve, PCGamer reports DIS Disney $194.43 / -0.7 (-0.36%) 02/17/21 Under Armour downgrade, Amazon target raise among top calls on Wall Street 02/12/21 Fly Intel: Wall Street's top stories for Friday 02/12/21 Fly Intel: Wall Street's top stories at midday 02/12/21 Fly Intel: Pre-market Movers 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference 03/09/21 The Walt Disney Company DIS Disney $194.43 / -0.7 (-0.36%) 02/12/21 Notable open interest changes for February 12th 01/25/21 Disney call volume above normal and directionally bullish 01/20/21 Unusually active option classes on open January 20th 12/29/20 Unusual call flow in option market yesterday

Events

Earnings calls, analyst events, roadshows and more

ENTA
Today at 16:00

Enanta Pharmaceuticals, Inc. Firm Sponsored Meetings
ROST
Today at 16:15

Ross Stores - ROST Conference Calls
VEC
Today at 16:30

Vectrus - VEC Conference Calls
NVEE
Today at 16:30

NV5 Global - NVEE Conference Calls
GO
Today at 16:30

Grocery Outlet - GO Conference Calls
VEEV
Today at 16:30

Veeva - VEEV Conference Calls
BGS
Today at 16:30

B&G Foods - BGS Conference Calls
AMBA
Today at 16:30

Ambarella - AMBA Conference Calls
RIGL
Today at 16:30

Rigel Pharmaceuticals - RIGL Conference Calls
LUNG
Today at 16:30

Pulmonx - LUNG Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright $9.23 1.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 16M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB $36.00-38.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler $5.25 Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James $141.28 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler $201.39 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan $62.68 1.75M Shares MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital $84.85 Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson $45.99 4.5M Shares SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton $32.22 10.6M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Moderna, Novavax advance as questions on AstraZeneca COVID vaccine arise

TODAY'S FREE FLY STORIES

Get Full Fly Access